Assignment of Assignor's Interest

Recorded: 2016-06-02 Pages: 4

Assignor

RICH, STEVEN A.

Executed: 2016-06-02

Assignee

QAAM PHARMACEUTICALS, LLC

4884 NORTH ROAD, CANANDAIGUA, NEW YORK, 14424

Covered Properties (7)

New Uses for Quaternary Ammonium Anticholinergic Muscarinic Receptor Antagonists in Patients Being Treated for Cognitive Impairment or Acute Delirium

Patent: 8,097,633 →

Application: 11/935,483 →

Publication: US 2008/0114014

New Uses for Quaternary Ammonium Anticholinergic Muscarinic Receptor Antagonists in Patients Being Treated for Cognitive Impairment or Acute Delirium

Patent: 9,084,753 →

Application: 13/325,371 →

Publication: US 2012/0088785

Combined Acetylcholinesterase Inhibitor and Quaternary Ammonium Antimuscarinic Therapy to Alter Progression of Cognitive Diseases

Patent: 8,969,402 →

Application: 13/778,530 →

Publication: US 2013/0172379

Combined Acetylcholinesterase Inhibitor and Quaternary Ammonium Antimuscarinic Therapy to Alter Progression of Cognitive Diseases

Patent: 9,034,890 →

Application: 13/778,556 →

Publication: US 2013/0172398

Quaternary Ammonium Anti-Cholinergic Muscarinic Receptor Antagonists

Patent: 9,980,941 →

Application: 14/513,631 →

Publication: US 2015/0031897

Use of Glycopyrrolate to Remedy Incontinence in Patients Being

Application: 60/865,893 →

Glycopyrronium Fatty Acid Salts and Methods of Making Same

Application: 62/175,737 →

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.